Anti-HIV-1 activity of trim 37

Journal of General Virology

Volumn 95, Issue PART 4, 2014, Pages 960-967

  Tabah, Azah A ^a,b   Tardif, Keith ^c   Mansky, Louis M ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c Myriad Pharmaceuticals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMID DNA; PROTEIN; SMALL INTERFERING RNA; TRIPARTITE MOTIF PROTEIN 37; UNCLASSIFIED DRUG; VIRUS DNA;

ANTIVIRAL ACTIVITY; ARTICLE; CELL STRAIN HEK293; CELL STRAIN HEPG2; DNA SYNTHESIS; HELA CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MOTIF; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRION; VIRUS INHIBITION; VIRUS REPLICATION;

DNA, VIRAL; HIV-1; HUMANS; NUCLEAR PROTEINS; VIRUS REPLICATION;

EID: 84897052823     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.057653-0     Document Type: Article

References (30)

1. Avela, K., Lipsanen-Nyman, M., Idanheimo, N., Seemanová, E., Rosengren, S., Makela, T. P., Perheentupa, J., Chapelle, A. D. & Lehesjoki, A. E. (2000). Gene encoding a new RING-B-box-coiled-coil protein is mutated in mulibrey nanism. Nat Genet 25, 298-301.
2. Best, S., Le Tissier, P., Towers, G. & Stoye, J. P. (1996). Positional cloning of the mouse retrovirus restriction gene Fv1. Nature 382, 826-829.
3. Bieniasz, P. D. (2004). Intrinsic immunity: a front-line defense against viral attack. Nat Immunol 5, 1109-1115.
4. Carr, J. M., Cheney, K. M., Coolen, C., Davis, A., Shaw, D., Ferguson, W., Chang, G., Higgins, G., Burrell, C. & Li, P. (2007). Development of methods for coordinate measurement of total cell-associated and integrated human immunodeficiency virus type 1 (HIV-1) DNA forms in routine clinical samples: levels are not associated with clinical parameters, but low levels of integrated HIV-1 DNA may be prognostic for continued successful therapy. J Clin Microbiol 45, 1288-1297.
5. Carthagena, L., Bergamaschi, A., Luna, J. M., David, A., Uchil, P. D., Margottin-Goguet, F., Mothes, W., Hazan, U., Transy, C. & other authors (2009). Human TRIM gene expression in response to interferons. PLoS ONE 4, e4894.
6. Dapp, M. J., Clouser, C. L., Patterson, S. & Mansky, L. M. (2009). 5-Azacytidine can induce lethal mutagenesis in human immunodeficiency virus type 1. J Virol 83, 11950-11958.
7. Diaz-Griffero, F., Kar, A., Lee, M., Stremlau, M., Poeschla, E. & Sodroski, J. (2007). Comparative requirements for the restriction of retrovirus infection by TRIM5a and TRIMCyp. Virology 369, 400-410.
8. Diaz-Griffero, F., Qin, X. R., Hayashi, F., Kigawa, T., Finzi, A., Sarnak, Z., Lienlaf, M., Yokoyama, S. & Sodroski, J. (2009). A B-box 2 surface patch important for TRIM5a self-association, capsid binding avidity, and retrovirus restriction. J Virol 83, 10737-10751.
9. Fridell, R. A., Harding, L. S., Bogerd, H. P. & Cullen, B. R. (1995). Identification of a novel human zinc finger protein that specifically interacts with the activation domain of lentiviral Tat proteins. Virology 209, 347-357.
10. Goff, S. P. (2007). Host factors exploited by retroviruses. Nat Rev Microbiol 5, 253-263.
11. Hamalainen, R. H., Joensuu, T., Kallijarvi, J. & Lehesjoki, A. E. (2006). Characterisation of the mulibrey nanism-associated TRIM37 gene: transcription initiation, promoter region and alternative splicing. Gene 366, 180-188.
12. Jolicoeur, P. & Rassart, E. (1980). Effect of Fv-1 gene product on synthesis of linear and supercoiled viral DNA in cells infected with murine leukemia virus. J Virol 33, 183-195.
13. Kajaste-Rudnitski, A., Marelli, S. S., Pultrone, C., Pertel, T., Uchil, P. D., Mechti, N., Mothes, W., Poli, G., Luban, J. & Vicenzi, E. (2011). TRIM22 inhibits HIV-1 transcription independently of its E3 ubiquitin ligase activity, Tat, and NF-kB-responsive long terminal repeat elements. J Virol 85, 5183-5196.
14. Kallijarvi, J., Hamalainen, R. H., Karlberg, N., Sainio, K. & Lehesjoki, A. E. (2006). Tissue expression of the mulibrey nanism-associated Trim37 protein in embryonic and adult mouse tissues. Histochem Cell Biol 126, 325-334.
15. Keckesova, Z., Ylinen, L. M. & Towers, G. J. (2004). The human and African green monkey TRIM5a genes encode Ref1 and Lv1 retroviral restriction factor activities. Proc Natl Acad Sci U S A 101, 10780-10785.
16. Lehesjoki, A. E., Reed, V. A., Mark Gardiner, R. & Greene, N. D. (2001). Expression of MUL, a gene encoding a novel RBCC family ring-finger protein, in human and mouse embryogenesis. Mech Dev 108, 221-225.
17. Perez-Caballero, D., Hatziioannou, T., Yang, A., Cowan, S. & Bieniasz, P. D. (2005). Human tripartite motif 5a domains responsible for retrovirus restriction activity and specificity. J Virol 79, 8969-8978.
18. Pertel, T., Hausmann, S., Morger, D., Zuger, S., Guerra, J., Lascano, J., Reinhard, C., Santoni, F. A., Uchil, P. D. & other authors (2011). TRIM5 is an innate immune sensor for the retrovirus capsid lattice. Nature 472, 361-365.
19. Reymond, A., Meroni, G., Fantozzi, A., Merla, G., Cairo, S., Luzi, L., Riganelli, D., Zanaria, E., Messali, S. & other authors (2001). The tripartite motif family identifies cell compartments. EMBO J 20, 2140-2151.
20. Rold, C. J. & Aiken, C. (2008). Proteasomal degradation of TRIM5a during retrovirus restriction. PLoS Pathog 4, e1000074.
21. Sastri, J., O'Connor, C., Danielson, C. M., McRaven, M., Perez, P., Diaz-Griffero, F. & Campbell, E. M. (2010). Identification of residues within the L2 region of rhesus TRIM5a that are required for retroviral restriction and cytoplasmic body localization. Virology 405, 259-266.
22. Stremlau, M., Owens, C. M., Perron, M. J., Kiessling, M., Autissier, P. & Sodroski, J. (2004). The cytoplasmic body component TRIM5a restricts HIV-1 infection in Old World monkeys. Nature 427, 848-853.
23. Stremlau, M., Perron, M., Lee, M., Li, Y., Song, B., Javanbakht, H., Diaz-Griffero, F., Anderson, D. J., Sundquist, W. I. & Sodroski, J. (2006). Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5a restriction factor. Proc Natl Acad Sci U S A 103, 5514-5519.
24. Towers, G. J. & Goff, S. P. (2003). Post-entry restriction of retroviral infections. AIDS Rev 5, 156-164.
25. Trkola, A. (2004). HIV-host interactions: vital to the virus and key to its inhibition. Curr Opin Microbiol 7, 555-559.
26. Uchil, P. D., Quinlan, B. D., Chan, W. T., Luna, J. M. & Mothes, W. (2008). TRIM E3 ligases interfere with early and late stages of the retroviral life cycle. PLoS Pathog 4, e16.
27. Voss, M., Paterson, J., Kelsall, I. R., Martín-Granados, C., Hastie, C. J., Peggie, M. W. & Cohen, P. T. (2011). Ppm1E is an in cellulo AMP-activated protein kinase phosphatase. Cell Signal 23, 114-124.
28. Wu, X., Anderson, J. L., Campbell, E. M., Joseph, A. M. & Hope, T. J. (2006). Proteasome inhibitors uncouple rhesus TRIM5a restriction of HIV-1 reverse transcription and infection. Proc Natl Acad Sci U S A 103, 7465-7470.
29. Zapata, J. M., Pawlowski, K., Haas, E., Ware, C. F., Godzik, A. & Reed, J. C. (2001). A diverse family of proteins containing tumor necrosis factor receptor-associated factor domains. J Biol Chem 276, 24242-24252.
30. Zhang, J., Ge, W., Zhan, P., De Clercq, E. & Liu, X. (2011). Retroviral restriction factors TRIM5a: therapeutic strategy to inhibit HIV-1 replication. Curr Med Chem 18, 2649-2654.